Alyeska Investment Group, L.P. Clene Inc. Transaction History
Alyeska Investment Group, L.P.
- $15.5 Billion
- Q1 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Clene Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 474,130 shares of CLNN stock, worth $170,686. This represents 0.0% of its overall portfolio holdings.
Number of Shares
474,130
Previous 1,686,890
71.89%
Holding current value
$170,686
Previous $506,000
59.88%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CLNN
# of Institutions
54Shares Held
7.44MCall Options Held
48.1KPut Options Held
160K-
Vanguard Group Inc Valley Forge, PA2.62MShares$943,0930.0% of portfolio
-
Geode Capital Management, LLC Boston, MA947KShares$340,7510.0% of portfolio
-
Lunt Capital Management, Inc. Holladay, UT513KShares$184,6300.11% of portfolio
-
Scoggin Management LP New York, NY500KShares$180,0000.08% of portfolio
-
Morgan Stanley New York, NY339KShares$121,9080.0% of portfolio
About Clene Inc.
- Ticker CLNN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,502,000
- Market Cap $22.9M
- Description
- Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...